Ensign Peak Advisors’s Verve Therapeutics VERV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,280	Closed	-$216K	–	2214
2022 Q3	$216K	Buy	6,280 +1,670	+36%	+$57.4K	﹤0.01%	1852
2022 Q2	$70K	Hold	4,610	–	–	﹤0.01%	2027
2022 Q1	$105K	Buy	4,610 +2,740	+147%	+$62.4K	﹤0.01%	2023
2021 Q4	$63K	Buy	+1,870	New	+$63K	﹤0.01%	2121